Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

China flag China · Delayed Price · Currency is CNY
6.97
-0.05 (-0.71%)
Mar 11, 2026, 11:25 AM CST
14.45%
Market Cap 3.53B
Revenue (ttm) 1.05B
Net Income (ttm) 172.02M
Shares Out 503.20M
EPS (ttm) 0.34
PE Ratio 20.53
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,096,668
Average Volume 34,098,167
Open 7.02
Previous Close 7.02
Day's Range 6.93 - 7.03
52-Week Range 5.21 - 8.60
Beta 0.33
RSI 47.01
Earnings Date Apr 28, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China. [Read more]

Sector Healthcare
Founded 1998
Employees 1,675
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002412
Full Company Profile

Financial Performance

In 2024, SHE:002412's revenue was 1.00 billion, an increase of 5.12% compared to the previous year's 955.53 million. Earnings were 220.24 million, an increase of 7.43%.

Financial Statements

News

There is no news available yet.